Schizophrenia and Disorders with Psychotic Features
Welcome,         Profile    Billing    Logout  
 86 Companies   134 Products   134 Products   85 Mechanisms of Action   5 Trials   1881 News 


«12345678910111213...3738»
  • ||||||||||  olanzapine / Generic mfg., sertraline / Generic mfg.
    Trial completion date, Trial primary completion date:  STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) -  May 1, 2018   
    P4,  N=269, Active, not recruiting, 
    Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018
  • ||||||||||  Trial completion date, Trial termination, Trial primary completion date:  Transcranial Direct Current Stimulation Influences on Cognitive Inhibition in Schizophrenia (clinicaltrials.gov) -  Apr 27, 2018   
    P=N/A,  N=30, Terminated, 
    Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Trial completion date: Oct 2015 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Mar 2018; Difficulty in financing the research
  • ||||||||||  Trial completion:  A Shared Decision-making Training for Inpatients With Schizophrenia (clinicaltrials.gov) -  Apr 25, 2018   
    P=N/A,  N=264, Completed, 
    Trial completion date: Oct 2015 --> Mar 2018 | Recruiting --> Terminated | Trial primary completion date: Sep 2015 --> Mar 2018; Difficulty in financing the research Active, not recruiting --> Completed
  • ||||||||||  Trial completion date, Trial primary completion date:  Social Cognition Training in Schizophrenia (clinicaltrials.gov) -  Apr 11, 2018   
    P=N/A,  N=25, Recruiting, 
    Active, not recruiting --> Completed | Phase classification: P2 --> PN/A Trial completion date: Jan 2018 --> Dec 2018 | Trial primary completion date: Jan 2018 --> Jun 2018
  • ||||||||||  Trial completion, Trial primary completion date:  Very Low Nicotine Cigarettes in Smokers With Schizophrenia (clinicaltrials.gov) -  Apr 9, 2018   
    P2,  N=58, Completed, 
    Trial completion date: Jan 2018 --> Dec 2018 | Trial primary completion date: Jan 2018 --> Jun 2018 Recruiting --> Completed | Trial primary completion date: Aug 2018 --> Aug 2017
  • ||||||||||  Phase classification:  Detecting Risk of Suicide in a Pediatric Emergency Department (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=524, Completed, 
    Recruiting --> Completed | Trial primary completion date: Aug 2018 --> Aug 2017 Phase classification: P=N/A --> P
  • ||||||||||  Phase classification, Enrollment change:  Brain Circuits in Schizophrenia and Smoking (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=42, Completed, 
    Phase classification: P=N/A --> P Phase classification: P=N/A --> P | N=300 --> 42
  • ||||||||||  Trial completion, Trial completion date:  Integrated Metacognitive Therapy in First Episode Psychosis (clinicaltrials.gov) -  Mar 30, 2018   
    P=N/A,  N=20, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Dec 2017
  • ||||||||||  Trial completion, Trial completion date:  Feeling of Being in Control of One's Own Action (clinicaltrials.gov) -  Mar 22, 2018   
    P=N/A,  N=198, Completed, 
    Recruiting --> Completed | N=36 --> 16 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017
  • ||||||||||  Arvisol (cannabidiol) / Echo Pharma
    Trial completion, Preclinical, Trial completion date, Trial primary completion date:  CBD-IS: Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study (clinicaltrials.gov) -  Mar 8, 2018   
    P1,  N=74, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Jun 2017 Recruiting --> Completed | Trial completion date: Apr 2017 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Aug 2017
  • ||||||||||  sodium valproate / Generic mfg.
    Trial completion, Trial completion date, Trial initiation date, Trial primary completion date:  Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia (clinicaltrials.gov) -  Feb 14, 2018   
    P4,  N=109, Completed, 
    Recruiting --> Completed | Trial completion date: Apr 2017 --> Aug 2017 | Trial primary completion date: Feb 2017 --> Aug 2017 Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017 | Initiation date: Mar 2013 --> Apr 2013 | Trial primary completion date: Oct 2017 --> Oct 2017
  • ||||||||||  Trial completion, Phase classification:  EmeraldThunder: rTMS in First Episode Psychosis (clinicaltrials.gov) -  Feb 14, 2018   
    P=N/A,  N=20, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Dec 2017 | Initiation date: Mar 2013 --> Apr 2013 | Trial primary completion date: Oct 2017 --> Oct 2017 Recruiting --> Completed | Phase classification: P2 --> PN/A
  • ||||||||||  aripiprazole / Generic mfg., olanzapine / Generic mfg.
    Trial completion, Phase classification, Trial completion date, Trial primary completion date, Adverse events:  Assessment of Adverse Events in a Naive Pediatric Population Treated With an Antipsychotic (clinicaltrials.gov) -  Feb 6, 2018   
    P=N/A,  N=200, Completed, 
    Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: May 2016 --> May 2017 | Trial completion date: Nov 2016 --> Jul 2017
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Cognitive Remediation and Sheltered Employment in Schizophrenia (clinicaltrials.gov) -  Jan 31, 2018   
    P=N/A,  N=79, Active, not recruiting, 
    Active, not recruiting --> Completed | Phase classification: P4 --> PN/A | Trial primary completion date: May 2016 --> May 2017 | Trial completion date: Nov 2016 --> Jul 2017 Recruiting --> Active, not recruiting | N=260 --> 79 | Trial primary completion date: May 2018 --> Sep 2018
  • ||||||||||  metformin / Generic mfg.
    Trial primary completion date:  Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness (clinicaltrials.gov) -  Jan 24, 2018   
    P4,  N=24, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Mar 2017 Trial primary completion date: Dec 2017 --> Jun 2018
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode (clinicaltrials.gov) -  Dec 7, 2017   
    P=N/A,  N=48, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | N=60 --> 48 | Trial primary completion date: Jul 2017 --> Nov 2016
  • ||||||||||  olanzapine / Generic mfg., sertraline / Generic mfg.
    Trial primary completion date:  STOP-PD: Sustaining Remission of Psychotic Depression (clinicaltrials.gov) -  Nov 9, 2017   
    P4,  N=269, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> May 2017 Trial primary completion date: Aug 2017 --> Mar 2018
  • ||||||||||  Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  SPA: A System for Preference Assessment in Mental Health (clinicaltrials.gov) -  Nov 6, 2017   
    P=N/A,  N=61, Completed, 
    Trial primary completion date: Aug 2017 --> Mar 2018 Recruiting --> Completed | N=90 --> 61 | Initiation date: Jan 2016 --> Jun 2014 | Trial primary completion date: Jul 2017 --> Oct 2017
  • ||||||||||  Trial primary completion date, Head-to-Head:  TaSCS: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country (clinicaltrials.gov) -  Oct 25, 2017   
    P3,  N=324, Active, not recruiting, 
    Recruiting --> Completed | N=90 --> 61 | Initiation date: Jan 2016 --> Jun 2014 | Trial primary completion date: Jul 2017 --> Oct 2017 Trial primary completion date: Jun 2017 --> Dec 2017
  • ||||||||||  Trial completion, Trial primary completion date:  The Partners Genetics Collaborative Study of Schizophrenia (clinicaltrials.gov) -  Oct 20, 2017   
    P=N/A,  N=451, Completed, 
    Trial primary completion date: Jun 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Oct 2017
  • ||||||||||  Trial completion, Trial initiation date:  Phase II Motivational Interviewing: An Experiential Online Training Tool (clinicaltrials.gov) -  Oct 16, 2017   
    P2,  N=3816, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Oct 2017 Recruiting --> Completed | Initiation date: Mar 2016 --> Aug 2016
  • ||||||||||  Enrollment change, Trial termination:  Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia (clinicaltrials.gov) -  Oct 12, 2017   
    P=N/A,  N=1556, Terminated, 
    Recruiting --> Completed | Initiation date: Mar 2016 --> Aug 2016 N=1975 --> 1556 | Recruiting --> Terminated
  • ||||||||||  Trial primary completion date:  Fingolimod in Schizophrenia Patients (clinicaltrials.gov) -  Oct 11, 2017   
    P2,  N=40, Active, not recruiting, 
    Recruiting --> Completed Trial primary completion date: Aug 2017 --> Dec 2017
  • ||||||||||  Trial termination:  Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) -  Oct 9, 2017   
    P=N/A,  N=123, Terminated, 
    Recruiting --> Active, not recruiting Completed --> Terminated
  • ||||||||||  Trial completion, Enrollment change:  Testing Effect and Schizophrenia (clinicaltrials.gov) -  Oct 6, 2017   
    P=N/A,  N=40, Completed, 
    Completed --> Terminated Recruiting --> Completed | N=50 --> 40
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Measuring Time Windows in Patients With Schizophrenia and Healthy Controls (clinicaltrials.gov) -  Oct 5, 2017   
    P=N/A,  N=126, Completed, 
    Recruiting --> Completed | N=50 --> 40 Recruiting --> Completed | N=228 --> 126 | Trial primary completion date: Dec 2017 --> Apr 2012
  • ||||||||||  Enrollment closed, Enrollment change, Trial primary completion date:  Feeling of Being in Control of One's Own Action (clinicaltrials.gov) -  Oct 5, 2017   
    P=N/A,  N=200, Active, not recruiting, 
    Recruiting --> Completed | N=228 --> 126 | Trial primary completion date: Dec 2017 --> Apr 2012 Recruiting --> Active, not recruiting | N=370 --> 200 | Trial primary completion date: Dec 2017 --> Jun 2017
  • ||||||||||  modafinil / Generic mfg.
    Enrollment change:  InO: Modafinil Effects on Cognition in Schizophrenia Patients (clinicaltrials.gov) -  Sep 29, 2017   
    P4,  N=29, Completed, 
    Recruiting --> Active, not recruiting | N=370 --> 200 | Trial primary completion date: Dec 2017 --> Jun 2017 N=40 --> 29
  • ||||||||||  Trial completion:  Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) -  Sep 21, 2017   
    P=N/A,  N=123, Completed, 
    N=40 --> 29 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial primary completion date:  Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder (clinicaltrials.gov) -  Sep 20, 2017   
    P=N/A,  N=350, Completed, 
    Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Trial completion, Phase classification, Trial initiation date, Trial primary completion date:  DCS: Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine (clinicaltrials.gov) -  Sep 19, 2017   
    P,  N=2, Completed, 
    Recruiting --> Completed Enrolling by invitation --> Completed | Phase classification: PN/A --> P | Initiation date: Jan 2015 --> Sep 2015 | Trial primary completion date: Jul 2017 --> Sep 2016